PharmaTalkRadio5 Helmi 2019

Why Are Clinical Trials Not Typically a Care Option?

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporate clinical research into care options for the patient?How to pave a path for possibilityUpdate on data to support how trials can be a care option This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA. The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Immuno-Oncology Debate 2024 on Solving Cancer’s Top Challenges

For more information, visit theconferenceforum.org

9 Joulu 202438min

CMO Misunderstandings about Clinical Operations and How to Improve

Many of the clinical trial delays and recruitment challenges in today's industry can be attributed to decisions made while designing the protocol and in the outsourcing strategy. Bringing clinical ope...

5 Joulu 202433min

How Roche is Maximizing the Impact of Patient Insights in Early Development

For more information, go to theconferenceforum.org

3 Joulu 202419min

Designing and Developing Drug Delivery for Lower and Middle-Income Countries

This podcast features a panel discussion on desgining and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and Abb...

21 Marras 202442min